Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Down 36.0% in May

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a large decline in short interest during the month of May. As of May 31st, there was short interest totalling 29,000 shares, a decline of 36.0% from the May 15th total of 45,300 shares. Based on an average trading volume of 15,500 shares, the days-to-cover ratio is currently 1.9 days.

Cardio Diagnostics Price Performance

Shares of NASDAQ CDIOW remained flat at $0.04 during trading on Friday. Cardio Diagnostics has a 12 month low of $0.03 and a 12 month high of $0.30. The business’s 50-day moving average is $0.07 and its 200-day moving average is $0.11.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.